Pharma Gifts Fuel Costly, Unnecessary Prescriptions

A comprehensive global review has found that financial incentives and gifts from pharmaceutical companies to doctors correlate with increased inappropriate prescribing. This practice leads to patients receiving medications that are more expensive, offer fewer benefits, or are not clinically necessary.

The analysis, which examined millions of doctors' prescribing practices across 93 studies, indicates that visits from sales representatives and sponsored events influence doctors' decisions. Lead author Professor Barbara Mintzes noted that doctors often underestimate this influence, believing small gifts like meals do not affect their judgment.

The review highlighted that even $13 meals can alter prescribing patterns, a finding supported by studies showing increased antibiotic prescriptions for colds and more frequent prescription of high-dose opioids among doctors with greater industry exposure.

While most included studies were US-based due to data availability, the findings are considered relevant globally, including in Australia. Despite Australia's medical code of conduct and disclosure logs, pharmaceutical lobbying remains common, raising concerns about potential conflicts of interest.

Implementing stronger conflict-of-interest policies in healthcare institutions and medical schools is proposed as a key strategy to enhance prescribing practices and better protect patients from undue industry influence.